Literature DB >> 2369117

Extracellular ATP stimulates an amiloride-sensitive sodium influx in human lymphocytes.

J S Wiley1, G P Jamieson, W Mayger, E J Cragoe, M Jopson.   

Abstract

Extracellular ATP has been shown to increase the Na+ permeability of human lymphocytes by 3 to 12-fold. The kinetics of this ATP-induced response were studied by measuring 22Na+ influx into chronic lymphocytic leukemic lymphocytes incubated in low-sodium media without divalent cations. ATP-stimulated uptake of 22Na-ions was linear over 4 min incubation and this influx component showed a sigmoid dependence on ATP concentration. Hill analysis yielded a K1/2 of 160 microM and a n value of 2.5. The nucleotide ATP-gamma-S (1-2 mM) gave 30% of the permeability increase produced by ATP, but UTP (2 mM) and dTTP (2 mM) had no effect on 22Na influx. The amiloride analogs 5-(N-ethyl-N-isopropyl) amiloride and 5-(N,N-hexamethylene) amiloride, which are potent inhibitors of Na(+)-H+ countertransport, abolished 72-95% of the ATP-stimulated 22Na+ influx. However, the involvement of Na(+)-H+ countertransport in the ATP-stimulated Na+ influx was excluded by three lines of evidence. Sodium influx was stimulated 7-fold by extracellular ATP but only 2.4-fold by hypertonic conditions which are known to activate Na(+)-H+ countertransport. Addition of ATP to lymphocytes produced no change in intracellular pH when these cells were suspended in isotonic NaCl media. Finally ATP caused a membrane depolarization of lymphocytes which is inconsistent with stimulation of electroneutral Na(+)-H+ exchange. These data suggest that ATP acts cooperatively to induce the formation of membrane channels which allow increased Na+ influx by a pathway which is partially inhibited by amiloride and its analogs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369117     DOI: 10.1016/0003-9861(90)90328-v

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.

Authors:  J S Wiley; J R Chen; M B Snook; G P Jamieson
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

Review 2.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

3.  Purinoceptor-operated cationic channels in human B lymphocytes.

Authors:  F Markwardt; M Löhn; T Böhm; M Klapperstück
Journal:  J Physiol       Date:  1997-01-01       Impact factor: 5.182

4.  Novel P2X7 receptor antagonists ease the pain.

Authors:  B F King
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

5.  Nonselective cationic currents elicited by extracellular ATP in human B-lymphocytes.

Authors:  F Bretschneider; M Klapperstück; M Löhn; F Markwardt
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

Review 6.  Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.

Authors:  Scott A Friedle; Marjorie A Curet; Jyoti J Watters
Journal:  Recent Pat CNS Drug Discov       Date:  2010-01

7.  Phospholipase D activation by P2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx.

Authors:  C E Gargett; E J Cornish; J S Wiley
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

8.  Agonists for endothelial P2 purinoceptors trigger a signalling pathway producing Ca2+ responses in lymphocytes adherent to endothelial cells.

Authors:  J S Wiley; J R Chen; G P Jamieson; P J Thurlow
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

9.  The therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: a combination approach with HAART.

Authors:  Marc C E Wagner
Journal:  Curr HIV Res       Date:  2011-06       Impact factor: 1.581

10.  Chemotactic activity of extracellular nucleotideson human immune cells.

Authors:  Daniel Myrtek; Marco Idzko
Journal:  Purinergic Signal       Date:  2007-03-08       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.